insights_auto
Why is 688068 down ४.०५%?
Dive Deeperchevron_right
688068:SHA
Beijing Hotgen Biotech Co Ltd
CN¥ ७२.७३
arrow_downward
-४.०५%(-३.०७) 1D
अक्टोबर १६, १५:००:०१ GMT+८ · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 688068...
Open
CN¥ ७७.८८
High
CN¥ ७९.४९
Low
CN¥ ७१.६८
Mkt. cap
७.१५ अरब
Avg. vol.
२२.७५ लाख
Volume
३०.९९ लाख
52-wk high
CN¥ २१४.७८
52-wk low
CN¥ ७१.६८
EPS
-CN¥ ३.००
No. of employees
१ हजार
Open
CN¥ ७७.८८
High
CN¥ ७९.४९
Low
CN¥ ७१.६८
Mkt. cap
७.१५ अरब
Avg. vol.
२२.७५ लाख
Volume
३०.९९ लाख
52-wk high
CN¥ २१४.७८
52-wk low
CN¥ ७१.६८
EPS
-CN¥ ३.००
No. of employees
१ हजार
News stories
From web sources and news partners
Law360
·
५२ मिनेट पहिले
Nasdaq Sued Over Delisting Of Social Media Co.
MarketBeat
·
२६ मिनेट पहिले
Billiontoone (NASDAQ:BLLN) CEO Sells $313,016.22 in Stock
Moomoo
·
३० मिनेट पहिले
28.2 Close
Seeking Alpha
·
५१ मिनेट पहिले
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
Profile
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification.
Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
About Beijing Hotgen Biotech Co Ltd